Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C1569> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- NCIT_C1569 IAO_0000115 "A recombinant monoclonal antibody interleukin-2 receptor antagonist. Daclizumab binds specifically to the alpha subunit of the human interleukin-2 (IL-2) receptor expressed on the surface of activated lymphocytes in vivo, thereby inhibiting IL-2 binding and IL-2-mediated lymphocyte activation, a critical cellular immune response pathway." @default.
- NCIT_C1569 NCIT_A32 NCIT_C1909 @default.
- NCIT_C1569 NCIT_NHC0 "C1569" @default.
- NCIT_C1569 NCIT_P106 "Amino Acid, Peptide, or Protein" @default.
- NCIT_C1569 NCIT_P106 "Immunologic Factor" @default.
- NCIT_C1569 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C1569 NCIT_P107 "Daclizumab" @default.
- NCIT_C1569 NCIT_P108 "Daclizumab" @default.
- NCIT_C1569 NCIT_P175 "725173" @default.
- NCIT_C1569 NCIT_P207 "C0663182" @default.
- NCIT_C1569 NCIT_P210 "152923-56-3" @default.
- NCIT_C1569 NCIT_P302 "Kidney transplant rejection, prevention" @default.
- NCIT_C1569 NCIT_P319 "CUJ2MVI71Y" @default.
- NCIT_C1569 NCIT_P322 "CTRP" @default.
- NCIT_C1569 NCIT_P322 "FDA" @default.
- NCIT_C1569 NCIT_P322 "GDC" @default.
- NCIT_C1569 NCIT_P325 "A monoclonal antibody that is being studied in the treatment of adult T-cell leukemia and in the treatment of cytopenia (low blood cell count)." @default.
- NCIT_C1569 NCIT_P329 "42006" @default.
- NCIT_C1569 NCIT_P330 "42006" @default.
- NCIT_C1569 NCIT_P366 "Daclizumab" @default.
- NCIT_C1569 NCIT_P375 "Daclizumab" @default.
- NCIT_C1569 NCIT_P399 "42006" @default.
- NCIT_C1569 NCIT_R124 NCIT_C17710 @default.
- NCIT_C1569 NCIT_R124 NCIT_C17828 @default.
- NCIT_C1569 NCIT_R124 NCIT_C18219 @default.
- NCIT_C1569 NCIT_R124 NCIT_C19986 @default.
- NCIT_C1569 NCIT_R124 NCIT_C40474 @default.
- NCIT_C1569 normalizedInformationContent "90.826665450122817" @default.
- NCIT_C1569 referenceCount "4" @default.
- NCIT_C1569 hasExactSynonym "Anti-Tac Humanized Monoclonal Antibody" @default.
- NCIT_C1569 hasExactSynonym "Anti-Tac Monoclonal Antibody" @default.
- NCIT_C1569 hasExactSynonym "Anti-Tac" @default.
- NCIT_C1569 hasExactSynonym "DACLIZUMAB" @default.
- NCIT_C1569 hasExactSynonym "Dacliximab" @default.
- NCIT_C1569 hasExactSynonym "Daclizumab" @default.
- NCIT_C1569 hasExactSynonym "Humanized Anti-Tac Monoclonal Antibody" @default.
- NCIT_C1569 hasExactSynonym "Monoclonal Antibody Anti-Tac" @default.
- NCIT_C1569 hasExactSynonym "Zenapax" @default.
- NCIT_C1569 hasExactSynonym "daclizumab" @default.
- NCIT_C1569 inSubset NCIT_C116977 @default.
- NCIT_C1569 inSubset NCIT_C116978 @default.
- NCIT_C1569 inSubset NCIT_C128784 @default.
- NCIT_C1569 inSubset NCIT_C157711 @default.
- NCIT_C1569 inSubset NCIT_C157712 @default.
- NCIT_C1569 inSubset NCIT_C176424 @default.
- NCIT_C1569 inSubset NCIT_C177537 @default.
- NCIT_C1569 inSubset NCIT_C63923 @default.
- NCIT_C1569 type Class @default.
- NCIT_C1569 isDefinedBy ncit.owl @default.
- NCIT_C1569 label "Daclizumab" @default.
- NCIT_C1569 subClassOf NCIT_C1569 @default.
- NCIT_C1569 subClassOf NCIT_C1908 @default.
- NCIT_C1569 subClassOf NCIT_C1909 @default.
- NCIT_C1569 subClassOf NCIT_C20401 @default.
- NCIT_C1569 subClassOf NCIT_C307 @default.
- NCIT_C1569 subClassOf NCIT_C308 @default.
- NCIT_C1569 subClassOf NCIT_C574 @default.
- NCIT_C1569 subClassOf NCIT_C75525 @default.